Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
Clinical trial NCT03315871 · COMPLETED
Trial details
- NCT number
- NCT03315871
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-20
- Primary completion
- 2024-06-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.